vTv Therapeutics Inc sell tamam
Start price
18.04.18
/
50%
€2.07
Target price
31.05.18
€1.08
Performance (%)
-7.83%
End price
31.05.18
€1.91
Summary
This prediction ended on 31.05.18 with a price of €1.91. With a performance of -7.83%, the SELL prediction by tamam was trending in the right direction. tamam has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| vTv Therapeutics Inc | - | - | - | - |
| iShares Core DAX® | 2,55 % | -0,11 % | 15,00 % | 49,60 % |
| iShares Nasdaq 100 | 2,74 % | -0,47 % | 30,95 % | 80,87 % |
| iShares Nikkei 225® | 6,58 % | 3,22 % | 49,70 % | 60,37 % |
| iShares S&P 500 | 1,93 % | -0,52 % | 24,88 % | 60,00 % |
Comments by tamam for this prediction
In the thread vTv Therapeutics Inc diskutieren
vTv Therapeutics' azeliragon flunks late-stage Alzheimer's study
Bottom feeders have stampeded into fallen biotech vTv Therapeutics
(Vom Mitglied beendet)


